We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.56%
This Fund
S&P 500
This Quarter
Est. Return
-2.31%
1 Year Est. Return
+50.56%
3 Year Est. Return
+139.16%
5 Year Est. Return
+175.94%
10 Year Est. Return
–
AUM
$65.9B
AUM Growth
-$6.77B
(-9.3%)
Cap. Flow
-$45M
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
38.99%
Holding
1,238
New
95
Increased
438
Reduced
526
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.23B |
| 2 |
Microsoft
MSFT
|
+$1.21B |
| 3 |
Tesla
TSLA
|
+$712M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$704M |
| 5 |
Chevron
CVX
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$612M |
| 2 |
Apple
AAPL
|
+$601M |
| 3 |
Procter & Gamble
PG
|
+$518M |
| 4 |
Texas Instruments
TXN
|
+$490M |
| 5 |
Pinduoduo
PDD
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.83% |
| 2 | Consumer Discretionary | 15.45% |
| 3 | Healthcare | 12.45% |
| 4 | Communication Services | 9.01% |
| 5 | Financials | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Paychex
PAYX
$45B
| $42M | 0.06% |
455,607
+254,727
| +127% | +$25.2M |
|
227
Corteva
CTVA
$55B
| $41.8M | 0.06% |
499,517
-403,529
| -45% | -$30.4M |
|
228
Burlington
BURL
$18.3B
| $41.2M | 0.06% |
126,742
+103,585
| +447% | +$31.7M |
|
229
Bio-Rad Laboratories Class A
BIO
$10.4B
| $41.2M | 0.06% |
147,834
+145,623
| +6,586% | +$41.9M |
|
230
FormFactor
FORM
$8.61B
| $41M | 0.06% |
422,827
-139,942
| -25% | -$12M |
|
231
Kinder Morgan
KMI
$70.2B
| $40.9M | 0.06% |
1,220,042
-1,977,900
| -62% | -$61.8M |
|
232
Suncor Energy
SU
$77.7B
| $40.4M | 0.06% |
611,716
+573,442
| +1,498% | +$31.7M |
|
|
AXON
233
Axon Enterprise
AXON
$49.7B
| $40.4M | 0.06% |
95,045
-112,384
| -54% | -$58.4M |
|
234
Teva Pharmaceuticals
TEVA
$43.8B
| $40.4M | 0.06% |
1,339,702
-833,046
| -38% | -$26.8M |
|
235
NiSource
NI
$19.6B
| $40.3M | 0.06% |
864,692
+358,329
| +71% | +$16.1M |
|
236
Peabody Energy
BTU
$3.59B
| $39.9M | 0.06% |
1,211,411
+930,451
| +331% | +$32.5M |
|
237
Dynatrace
DT
$15.4B
| $39.9M | 0.06% |
1,078,560
+480,734
| +80% | +$18.4M |
|
238
IQVIA
IQV
$43.2B
| $39.4M | 0.06% |
231,192
+7,467
| +3% | +$1.46M |
|
|
NVMI
239
Nova
NVMI
$11.8B
| $39.1M | 0.06% |
90,955
+14,332
| +19% | +$6.31M |
|
240
Pultegroup
PHM
$24.1B
| $38.8M | 0.06% |
329,830
+226,723
| +220% | +$29M |
|
241
Amneal Pharmaceuticals
AMRX
$6.27B
| $38.1M | 0.06% |
3,067,361
-694,378
| -18% | -$9.32M |
|
242
Hartford Financial Services
HIG
$37.3B
| $38M | 0.06% |
280,884
+170,452
| +154% | +$23.3M |
|
243
Kinross Gold
KGC
$38.6B
| $38M | 0.06% |
1,244,228
+634,072
| +104% | +$20.8M |
|
244
Dow Inc
DOW
$21.9B
| $38M | 0.06% |
911,383
+889,372
| +4,041% | +$28.2M |
|
245
Kirby Corp
KEX
$7.38B
| $37.4M | 0.06% |
281,505
+66,526
| +31% | +$8.43M |
|
246
HCA Healthcare
HCA
$90.8B
| $37.3M | 0.06% |
78,780
-14,876
| -16% | -$7.49M |
|
247
Synchrony
SYF
$26B
| $37.1M | 0.06% |
545,880
+494,354
| +959% | +$35.9M |
|
248
Emerson Electric
EMR
$88B
| $37.1M | 0.06% |
283,097
-265,726
| -48% | -$38.2M |
|
249
XP
XP
$8.97B
| $36.8M | 0.06% |
1,930,445
+1,146,057
| +146% | +$22.1M |
|
250
Zoom
ZM
$29.4B
| $36M | 0.05% |
447,561
-524,922
| -54% | -$44M |
|
Similar funds
CBU
Assenagon Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Assenagon Asset Management held 1,238 positions worth $65.9B, down 9.3% from $72.6B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Assenagon Asset Management's Q1 2026 filing shows 95 new, 438 increased, 526 reduced and 143 closed positions. Its largest new stake was Webster Financial: 1,581,021 shares worth $110M. The largest sale was Costco, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Assenagon Asset Management's largest Q1 2026 buy was Webster Financial: 1,581,021 shares worth $110M.
- Assenagon Asset Management added most to Eli Lilly in Q1 2026, an estimated $1.23B increase.
- Assenagon Asset Management's biggest Q1 2026 reduction was Costco, cutting an estimated $612M.
- Assenagon Asset Management fully exited Praxis Precision Medicines in Q1 2026, selling an estimated $120M.
- Assenagon Asset Management's ten largest holdings make up 39% of its $65.9B portfolio in Q1 2026.
- Assenagon Asset Management opened 95 new positions and closed 143 in Q1 2026.
- Assenagon Asset Management's portfolio value fell 9.3% quarter-over-quarter to $65.9B.
Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.